Dysfunctional lung anatomy and small airways degeneration in COPD

International Journal of COPD

Volumn 8, Issue , 2013, Pages 7-13

  Martin, Clémence ^a   Frija, Justine ^a   Burgel, Pierre Régis ^a  

^a AP HP and Université Paris Descartes Sorbonne Paris Cité ^*  (France)

Author keywords

Adaptive immunity; Airway mucus; Emphysema; Innate immunity; Small airways disease

Indexed keywords

BRONCHODILATING AGENT; CIGARETTE SMOKE; STEROID;

AIRWAY OBSTRUCTION; AIRWAY RESISTANCE; AUTOIMMUNITY; BRONCHIOLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECT; HUMAN; INFLAMMATORY CELL; LUNG EMPHYSEMA; LUNG FIBROSIS; NONHUMAN; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; RESPIRATORY TRACT INFLAMMATION; REVIEW; SMALL AIRWAY DISEASE;

ADAPTIVE IMMUNITY; AIRWAY MUCUS; EMPHYSEMA; INNATE IMMUNITY; SMALL AIRWAYS DISEASE;

AIRWAY OBSTRUCTION; AIRWAY REMODELING; AIRWAY RESISTANCE; BRONCHIOLES; EPITHELIAL CELLS; FIBROSIS; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; PULMONARY ALVEOLI; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA;

EID: 84872304206     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S28290     Document Type: Review

References (48)

1. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. August 9, 2012. [Epub ahead of print.]
2. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733-743.
3. Horsfield K, Cumming G. Morphology of the bronchial tree in man. J Appl Physiol. 1968;24:373-383.
4. Burgel PR. The role of small airways in obstructive airway diseases. Eur Respir Rev. 2011;20:23-33.
5. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278: 1355-1360.
6. Yanai M, Sekizawa K, Ohrui T, Sasaki H, Takishima T. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol. 1992;72:1016-1023.
7. Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med. 1978;298:1277-1281.
8. Howard CV, Reed MG, editors. Unbiased Stereology. Three-Dimensional Measurement In Microscopy. Oxford, UK: BIOS Scientific Publishers Limited; 1998.
9. Diaz AA, Valim C, Yamashiro T, et al. Airway count and emphysema assessed by chest CT imaging predicts clinical outcome in smokers. Chest. 2010;138:880-887.
10. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365:1567-1575.
11. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645-2653.
12. Araya J, Cambier S, Markovics JA, et al. Squamous metaplasia ampli-fies pathologic epithelial-mesenchymal interactions in COPD patients. J Clin Invest. 2007;117:3551-3562.
13. Saetta M, Turato G, Baraldo S, et al. Goblet cell hyperplasia and epithe-lial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med. 2000;161:1016-1021.
14. Mitchell RS, Stanford RE, Johnson JM, Silvers GW, Dart G, George MS. The morphologic features of the bronchi, bronchioles, and alveoli in chronic airway obstruction: a clinicopathologic study. Am Rev Respir Dis. 1976;114:137-145.
15. Caramori G, Di Gregorio C, Carlstedt I, et al. Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease. Histopathology. 2004;45:477-484.
16. Snider GL, Kleinerman J, Thurlbeck WM, Bengali ZH. The definition of emphysema: report of a National Heart, Lung, and Blood Institute workshop. Am Rev Respir Dis. 1985;132:182-185.
17. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2:258-266.
18. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005;365:2225-2236.
19. Snider GL, Sherter CB. A one-year study of the evolution of elastase-induced emphysema in hamsters. J Appl Physiol. 1977;43:721-729.
20. Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest. 2012;122:2749-2755.
21. Imai K, Mercer BA, Schulman LL, Sonett JR, D'Armiento JM. Correlation of lung surface area to apoptosis and proliferation in human emphysema. Eur Respir J. 2005;25:250-258.
22. Yokohori N, Aoshiba K, Nagai A. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. Chest. 2004;125:626-632.
23. Tsuji T, Aoshiba K, Nagai A. Alveolar cell senescence in patients with pulmonary emphysema. Am J Respir Crit Care Med. 2006;174: 886-893.
24. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstruc-tive pulmonary disease. N Engl J Med. 2009;360:2445-2454.
25. Agustí A, MacNee W, Donaldson K, Cosio M. Hypothesis: does COPD have an autoimmune component? Thorax. 2003;58:832-834.
26. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, et al. An animal model of autoimmune emphysema. Am J Respir Crit Care Med. 2005;171:734-742.
27. Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med. 2007;13:567-569.
28. Rinaldi M, Lehouck A, Heulens N, et al. Antielastin B-cell and T-cell immunity in patients with chronic obstructive pulmonary disease. Thorax. 2012;67:694-700.
29. Greene CM, Low TB, O'Neill SJ, McElvaney NG. Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflam-matory lung disease. Am J Respir Crit Care Med. 2010;181:31-35.
30. Mitzner W. Emphysema - a disease of small airways or lung paren-chyma? N Engl J Med. 2011;365:1637-1639.
31. Galbán CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18:1711-1715.
32. Burgel PR, Bourdin A, Chanez P, et al. Update on the roles of distal airways in COPD. Eur Respir Rev. 2011;20:7-22.
33. Barnes PJ. The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2009;41:631-638.
34. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:1304-1309.
35. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011;378: 1015-1026.
36. Lams BE, Sousa AR, Rees PJ, Lee TH. Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pul-monary disease. Am J Respir Crit Care Med. 1998;158:1518-1523.
37. Saetta M, Baraldo S, Corbino L, et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160:711-717.
38. Saetta M, Di Stefano A, Turato G, et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:822-826.
39. Demedts IK, Bracke KR, Van Pottelberge G, et al. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:998-1005.
40. Freeman CM, Martinez FJ, Han MK, et al. Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180: 1179-1188.
41. Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflam-mation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173:1114-1121.
42. Andersson CK, Mori M, Bjermer L, Lofdahl CG, Erjefalt JS. Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181: 206-217.
43. Ballarin A, Bazzan E, Hernandez Zenteno R, et al. Mast cell infiltra-tion discriminates between histopathological phenotypes of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186:233-239.
44. Saetta M, Ghezzo H, Kim WD, et al. Loss of alveolar attachments in smokers. A morphometric correlate of lung function impairment. Am Rev Respir Dis. 1985;132:894-900.
45. Kim V, Kelemen SE, Abuel-Haija M, et al. Small airway mucous metaplasia and inflammation in chronic obstructive pulmonary disease. COPD. 2008;5:329-338.
46. Burgel PR, Nadel JA. Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Respir J. 2008;32:1068-1081.
47. Vernooy JH, Moller GM, van Suylen RJ, et al. Increased granzyme A expression in type II pneumocytes of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175: 464-472.
48. Nadel JA. Role of neutrophil elastase in hypersecretion during COPD exacerbations, and proposed therapies. Chest. 2000;117:386S-389S.